Revenue | ₹6,247.50Cr |
Net Profits | ₹610.35Cr |
Net Profit Margins | 9.77% |
Glenmark Pharmaceuticals Ltd’s revenue jumped 79.88% since last year same period to ₹6,247.50Cr in the Q2 2025-2026. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated 89.84% jump in its revenue since last 3-months.
Glenmark Pharmaceuticals Ltd’s net profit jumped 72.31% since last year same period to ₹610.35Cr in the Q2 2025-2026. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated 1202.22% jump in its net profits since last 3-months.
Glenmark Pharmaceuticals Ltd’s net profit margin fell -4.2% since last year same period to 9.77% in the Q2 2025-2026. On a quarterly growth basis, Glenmark Pharmaceuticals Ltd has generated 585.95% jumped in its net profit margins since last 3-months.
The revenue for Glenmark Pharmaceuticals Ltd in the Q2 results 2025 was ₹6,247.50Cr.
The net profit for Glenmark Pharmaceuticals Ltd in the Q2 results 2025 was ₹610.35Cr.
The net profit margin for Glenmark Pharmaceuticals Ltd in the Q2 results 2025 was 9.77%.
The revenue for Glenmark Pharmaceuticals Ltd in the Q2 results 2024 was ₹3,473.21Cr.
The net profit for Glenmark Pharmaceuticals Ltd in the Q2 results 2024 was ₹354.21Cr.
The net profit margin for Glenmark Pharmaceuticals Ltd in the Q2 results 2024 was 10.20%.